Cantor Fitzgerald Reiterates Overweight on Tenet Healthcare, Maintains $168 Price Target
Portfolio Pulse from Benzinga Newsdesk
Cantor Fitzgerald analyst Sarah James has reiterated an Overweight rating on Tenet Healthcare (NYSE:THC) and maintained a price target of $168.
August 20, 2024 | 3:26 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Cantor Fitzgerald analyst Sarah James has reiterated an Overweight rating on Tenet Healthcare and maintained a price target of $168, indicating confidence in the company's stock performance.
The reiteration of an Overweight rating and a maintained price target of $168 by a reputable analyst suggests a positive outlook for Tenet Healthcare's stock, likely leading to a short-term price increase.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100